Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2017 | 12-2006 | 12-1994 | 12-1993 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,828 | N/A | N/A | 11,896 | 25,517 |
| Depreciation Amortization | 469 | N/A | N/A | 726 | 716 |
| Accounts payable and accrued liabilities | 558 | N/A | N/A | N/A | N/A |
| Other Working Capital | 1,866 | N/A | N/A | -7,841 | -37,711 |
| Other Operating Activity | -149 | 0 | 0 | 3,184 | 17,764 |
| Operating Cash Flow | $-10,084 | $N/A | $N/A | $7,965 | $6,286 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,483 | N/A | N/A | -2,622 | -1,221 |
| Net Acquisitions | N/A | N/A | N/A | -2,898 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -19,735 | -12,087 |
| Investing Cash Flow | $-1,483 | $N/A | $N/A | $-25,255 | $-13,308 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 35 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 544 | -988 |
| Financing Cash Flow | $35 | $N/A | $N/A | $544 | $-988 |
| Beginning Cash Position | 19,720 | N/A | N/A | 30,863 | 38,873 |
| End Cash Position | 8,188 | N/A | N/A | 16,962 | 30,863 |
| Net Cash Flow | $-11,532 | $N/A | $N/A | $-13,901 | $-8,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,084 | N/A | N/A | 7,965 | 6,286 |
| Capital Expenditure | -1,483 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -11,567 | 0 | 0 | 7,965 | 6,286 |